Table of Content

1 Drugs for HIV Market Overview
1.1 Drugs for HIV Product Overview
1.2 Drugs for HIV Market Segment by Type
1.2.1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.2.2 Integrase Inhibitors
1.2.3 Combination HIV Medicines
1.2.4 Others
1.3 Global Drugs for HIV Market Size by Type
1.3.1 Global Drugs for HIV Market Size Overview by Type (2024-2034)
1.3.2 Global Drugs for HIV Historic Market Size Review by Type (2024-2024)
1.3.3 Global Drugs for HIV Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Drugs for HIV Sales Breakdown by Type (2024-2024)
1.4.2 Europe Drugs for HIV Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Drugs for HIV Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Drugs for HIV Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Drugs for HIV Sales Breakdown by Type (2024-2024)
2 Global Drugs for HIV Market Competition by Company
2.1 Global Top Players by Drugs for HIV Sales (2024-2024)
2.2 Global Top Players by Drugs for HIV Revenue (2024-2024)
2.3 Global Top Players by Drugs for HIV Price (2024-2024)
2.4 Global Top Manufacturers Drugs for HIV Manufacturing Base Distribution, Sales Area, Product Type
2.5 Drugs for HIV Market Competitive Situation and Trends
2.5.1 Drugs for HIV Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Drugs for HIV Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for HIV as of 2022)
2.7 Date of Key Manufacturers Enter into Drugs for HIV Market
2.8 Key Manufacturers Drugs for HIV Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Drugs for HIV Status and Outlook by Region
3.1 Global Drugs for HIV Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Drugs for HIV Historic Market Size by Region
3.2.1 Global Drugs for HIV Sales in Volume by Region (2024-2024)
3.2.2 Global Drugs for HIV Sales in Value by Region (2024-2024)
3.2.3 Global Drugs for HIV Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Drugs for HIV Forecasted Market Size by Region
3.3.1 Global Drugs for HIV Sales in Volume by Region (2024-2034)
3.3.2 Global Drugs for HIV Sales in Value by Region (2024-2034)
3.3.3 Global Drugs for HIV Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Drugs for HIV by Application
4.1 Drugs for HIV Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.1.4 Others
4.2 Global Drugs for HIV Market Size by Application
4.2.1 Global Drugs for HIV Market Size Overview by Application (2024-2034)
4.2.2 Global Drugs for HIV Historic Market Size Review by Application (2024-2024)
4.2.3 Global Drugs for HIV Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Drugs for HIV Sales Breakdown by Application (2024-2024)
4.3.2 Europe Drugs for HIV Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Drugs for HIV Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Drugs for HIV Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Drugs for HIV Sales Breakdown by Application (2024-2024)
5 North America Drugs for HIV by Country
5.1 North America Drugs for HIV Historic Market Size by Country
5.1.1 North America Drugs for HIV Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Drugs for HIV Sales in Volume by Country (2024-2024)
5.1.3 North America Drugs for HIV Sales in Value by Country (2024-2024)
5.2 North America Drugs for HIV Forecasted Market Size by Country
5.2.1 North America Drugs for HIV Sales in Volume by Country (2024-2034)
5.2.2 North America Drugs for HIV Sales in Value by Country (2024-2034)
6 Europe Drugs for HIV by Country
6.1 Europe Drugs for HIV Historic Market Size by Country
6.1.1 Europe Drugs for HIV Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Drugs for HIV Sales in Volume by Country (2024-2024)
6.1.3 Europe Drugs for HIV Sales in Value by Country (2024-2024)
6.2 Europe Drugs for HIV Forecasted Market Size by Country
6.2.1 Europe Drugs for HIV Sales in Volume by Country (2024-2034)
6.2.2 Europe Drugs for HIV Sales in Value by Country (2024-2034)
7 Asia-Pacific Drugs for HIV by Region
7.1 Asia-Pacific Drugs for HIV Historic Market Size by Region
7.1.1 Asia-Pacific Drugs for HIV Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Drugs for HIV Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Drugs for HIV Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Drugs for HIV Forecasted Market Size by Region
7.2.1 Asia-Pacific Drugs for HIV Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Drugs for HIV Sales in Value by Region (2024-2034)
8 Latin America Drugs for HIV by Country
8.1 Latin America Drugs for HIV Historic Market Size by Country
8.1.1 Latin America Drugs for HIV Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Drugs for HIV Sales in Volume by Country (2024-2024)
8.1.3 Latin America Drugs for HIV Sales in Value by Country (2024-2024)
8.2 Latin America Drugs for HIV Forecasted Market Size by Country
8.2.1 Latin America Drugs for HIV Sales in Volume by Country (2024-2034)
8.2.2 Latin America Drugs for HIV Sales in Value by Country (2024-2034)
9 Middle East and Africa Drugs for HIV by Country
9.1 Middle East and Africa Drugs for HIV Historic Market Size by Country
9.1.1 Middle East and Africa Drugs for HIV Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Drugs for HIV Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Drugs for HIV Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Drugs for HIV Forecasted Market Size by Country
9.2.1 Middle East and Africa Drugs for HIV Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Drugs for HIV Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 ViiV Healthcare
10.1.1 ViiV Healthcare Company Information
10.1.2 ViiV Healthcare Introduction and Business Overview
10.1.3 ViiV Healthcare Drugs for HIV Sales, Revenue and Gross Margin (2024-2024)
10.1.4 ViiV Healthcare Drugs for HIV Products Offered
10.1.5 ViiV Healthcare Recent Development
10.2 Gilead Sciences, Inc
10.2.1 Gilead Sciences, Inc Company Information
10.2.2 Gilead Sciences, Inc Introduction and Business Overview
10.2.3 Gilead Sciences, Inc Drugs for HIV Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Gilead Sciences, Inc Drugs for HIV Products Offered
10.2.5 Gilead Sciences, Inc Recent Development
10.3 Merck Sharp & Dohme Corp
10.3.1 Merck Sharp & Dohme Corp Company Information
10.3.2 Merck Sharp & Dohme Corp Introduction and Business Overview
10.3.3 Merck Sharp & Dohme Corp Drugs for HIV Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Merck Sharp & Dohme Corp Drugs for HIV Products Offered
10.3.5 Merck Sharp & Dohme Corp Recent Development
10.4 Bristol-Myers Squibb Company
10.4.1 Bristol-Myers Squibb Company Company Information
10.4.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Company Drugs for HIV Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Bristol-Myers Squibb Company Drugs for HIV Products Offered
10.4.5 Bristol-Myers Squibb Company Recent Development
10.5 Janssen Pharmaceuticals, Inc.
10.5.1 Janssen Pharmaceuticals, Inc. Company Information
10.5.2 Janssen Pharmaceuticals, Inc. Introduction and Business Overview
10.5.3 Janssen Pharmaceuticals, Inc. Drugs for HIV Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Janssen Pharmaceuticals, Inc. Drugs for HIV Products Offered
10.5.5 Janssen Pharmaceuticals, Inc. Recent Development
10.6 Theratechnologies Inc.
10.6.1 Theratechnologies Inc. Company Information
10.6.2 Theratechnologies Inc. Introduction and Business Overview
10.6.3 Theratechnologies Inc. Drugs for HIV Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Theratechnologies Inc. Drugs for HIV Products Offered
10.6.5 Theratechnologies Inc. Recent Development
10.7 Mylan Pharmaceuticals Inc.
10.7.1 Mylan Pharmaceuticals Inc. Company Information
10.7.2 Mylan Pharmaceuticals Inc. Introduction and Business Overview
10.7.3 Mylan Pharmaceuticals Inc. Drugs for HIV Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Mylan Pharmaceuticals Inc. Drugs for HIV Products Offered
10.7.5 Mylan Pharmaceuticals Inc. Recent Development
10.8 Genentech, Inc.
10.8.1 Genentech, Inc. Company Information
10.8.2 Genentech, Inc. Introduction and Business Overview
10.8.3 Genentech, Inc. Drugs for HIV Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Genentech, Inc. Drugs for HIV Products Offered
10.8.5 Genentech, Inc. Recent Development
10.9 AbbVie Inc.
10.9.1 AbbVie Inc. Company Information
10.9.2 AbbVie Inc. Introduction and Business Overview
10.9.3 AbbVie Inc. Drugs for HIV Sales, Revenue and Gross Margin (2024-2024)
10.9.4 AbbVie Inc. Drugs for HIV Products Offered
10.9.5 AbbVie Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Drugs for HIV Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Drugs for HIV Industrial Chain Analysis
11.4 Drugs for HIV Market Dynamics
11.4.1 Drugs for HIV Industry Trends
11.4.2 Drugs for HIV Market Drivers
11.4.3 Drugs for HIV Market Challenges
11.4.4 Drugs for HIV Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Drugs for HIV Distributors
12.3 Drugs for HIV Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 2. Major Company of Integrase Inhibitors
Table 3. Major Company of Combination HIV Medicines
Table 4. Major Company of Others
Table 5. Global Drugs for HIV Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Drugs for HIV Sales by Type (2024-2024) & (K Units)
Table 7. Global Drugs for HIV Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Drugs for HIV Sales by Type (2024-2024) & (US& Million)
Table 9. Global Drugs for HIV Market Share in Value by Type (2024-2024)
Table 10. Global Drugs for HIV Price by Type (2024-2024) & (US$/Unit)
Table 11. Global Drugs for HIV Sales by Type (2024-2034) & (K Units)
Table 12. Global Drugs for HIV Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Drugs for HIV Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Drugs for HIV Sales Market Share in Value by Type (2024-2034)
Table 15. Global Drugs for HIV Price by Type (2024-2034) & (US$/Unit)
Table 16. North America Drugs for HIV Sales by Type (2024-2024) & (K Units)
Table 17. North America Drugs for HIV Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Drugs for HIV Sales (K Units) by Type (2024-2024)
Table 19. Europe Drugs for HIV Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Drugs for HIV Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Drugs for HIV Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Drugs for HIV Sales (K Units) by Type (2024-2024)
Table 23. Latin America Drugs for HIV Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Drugs for HIV Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Drugs for HIV Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Drugs for HIV Sales by Company (2024-2024) & (K Units)
Table 27. Global Drugs for HIV Sales Share by Company (2024-2024)
Table 28. Global Drugs for HIV Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Drugs for HIV Revenue Share by Company (2024-2024)
Table 30. Global Market Drugs for HIV Price by Company (2024-2024) & (US$/Unit)
Table 31. Global Drugs for HIV Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Drugs for HIV Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for HIV as of 2022)
Table 34. Date of Key Manufacturers Enter into Drugs for HIV Market
Table 35. Key Manufacturers Drugs for HIV Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Drugs for HIV Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Drugs for HIV Sales by Region (2024-2024) & (K Units)
Table 39. Global Drugs for HIV Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Drugs for HIV Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Drugs for HIV Sales Market Share in Value by Region (2024-2024)
Table 42. Global Drugs for HIV Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 43. Global Drugs for HIV Sales by Region (2024-2034) & (K Units)
Table 44. Global Drugs for HIV Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Drugs for HIV Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Drugs for HIV Sales Market Share in Value by Region (2024-2034)
Table 47. Global Drugs for HIV Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 48. Global Drugs for HIV Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Drugs for HIV Sales by Application (2024-2024) & (K Units)
Table 50. Global Drugs for HIV Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Drugs for HIV Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Drugs for HIV Sales Market Share in Value by Application (2024-2024)
Table 53. Global Drugs for HIV Price by Application (2024-2024) & (US$/Unit)
Table 54. Global Drugs for HIV Sales by Application (2024-2034) & (K Units)
Table 55. Global Drugs for HIV Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Drugs for HIV Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Drugs for HIV Sales Market Share in Value by Application (2024-2034)
Table 58. Global Drugs for HIV Price by Application (2024-2034) & (US$/Unit)
Table 59. North America Drugs for HIV Sales by Application (2024-2024) (K Units)
Table 60. North America Drugs for HIV Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Drugs for HIV Sales by Application (2024-2024) (K Units)
Table 62. Europe Drugs for HIV Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Drugs for HIV Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Drugs for HIV Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Drugs for HIV Sales by Application (2024-2024) (K Units)
Table 66. Latin America Drugs for HIV Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Drugs for HIV Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Drugs for HIV Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Drugs for HIV Sales by Country (2024-2024) & (K Units)
Table 70. North America Drugs for HIV Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Drugs for HIV Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Drugs for HIV Sales Market Share in Value by Country (2024-2024)
Table 73. North America Drugs for HIV Sales by Country (2024-2034) & (K Units)
Table 74. North America Drugs for HIV Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Drugs for HIV Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Drugs for HIV Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Drugs for HIV Sales by Country (2024-2024) & (K Units)
Table 78. Europe Drugs for HIV Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Drugs for HIV Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Drugs for HIV Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Drugs for HIV Sales by Country (2024-2034) & (K Units)
Table 82. Europe Drugs for HIV Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Drugs for HIV Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Drugs for HIV Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Drugs for HIV Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Drugs for HIV Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Drugs for HIV Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Drugs for HIV Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Drugs for HIV Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Drugs for HIV Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Drugs for HIV Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Drugs for HIV Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Drugs for HIV Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Drugs for HIV Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Drugs for HIV Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Drugs for HIV Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Drugs for HIV Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Drugs for HIV Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Drugs for HIV Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Drugs for HIV Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Drugs for HIV Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Drugs for HIV Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Drugs for HIV Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Drugs for HIV Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Drugs for HIV Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Drugs for HIV Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Drugs for HIV Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Drugs for HIV Sales Market Share in Value by Country (2024-2034)
Table 109. ViiV Healthcare Company Information
Table 110. ViiV Healthcare Introduction and Business Overview
Table 111. ViiV Healthcare Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 112. ViiV Healthcare Drugs for HIV Product
Table 113. ViiV Healthcare Recent Development
Table 114. Gilead Sciences, Inc Company Information
Table 115. Gilead Sciences, Inc Introduction and Business Overview
Table 116. Gilead Sciences, Inc Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 117. Gilead Sciences, Inc Drugs for HIV Product
Table 118. Gilead Sciences, Inc Recent Development
Table 119. Merck Sharp & Dohme Corp Company Information
Table 120. Merck Sharp & Dohme Corp Introduction and Business Overview
Table 121. Merck Sharp & Dohme Corp Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 122. Merck Sharp & Dohme Corp Drugs for HIV Product
Table 123. Merck Sharp & Dohme Corp Recent Development
Table 124. Bristol-Myers Squibb Company Company Information
Table 125. Bristol-Myers Squibb Company Introduction and Business Overview
Table 126. Bristol-Myers Squibb Company Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 127. Bristol-Myers Squibb Company Drugs for HIV Product
Table 128. Bristol-Myers Squibb Company Recent Development
Table 129. Janssen Pharmaceuticals, Inc. Company Information
Table 130. Janssen Pharmaceuticals, Inc. Introduction and Business Overview
Table 131. Janssen Pharmaceuticals, Inc. Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 132. Janssen Pharmaceuticals, Inc. Drugs for HIV Product
Table 133. Janssen Pharmaceuticals, Inc. Recent Development
Table 134. Theratechnologies Inc. Company Information
Table 135. Theratechnologies Inc. Introduction and Business Overview
Table 136. Theratechnologies Inc. Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 137. Theratechnologies Inc. Drugs for HIV Product
Table 138. Theratechnologies Inc. Recent Development
Table 139. Mylan Pharmaceuticals Inc. Company Information
Table 140. Mylan Pharmaceuticals Inc. Introduction and Business Overview
Table 141. Mylan Pharmaceuticals Inc. Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 142. Mylan Pharmaceuticals Inc. Drugs for HIV Product
Table 143. Mylan Pharmaceuticals Inc. Recent Development
Table 144. Genentech, Inc. Company Information
Table 145. Genentech, Inc. Introduction and Business Overview
Table 146. Genentech, Inc. Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 147. Genentech, Inc. Drugs for HIV Product
Table 148. Genentech, Inc. Recent Development
Table 149. AbbVie Inc. Company Information
Table 150. AbbVie Inc. Introduction and Business Overview
Table 151. AbbVie Inc. Drugs for HIV Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 152. AbbVie Inc. Drugs for HIV Product
Table 153. AbbVie Inc. Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Drugs for HIV Market Trends
Table 157. Drugs for HIV Market Drivers
Table 158. Drugs for HIV Market Challenges
Table 159. Drugs for HIV Market Restraints
Table 160. Drugs for HIV Distributors List
Table 161. Drugs for HIV Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for HIV Product Picture
Figure 2. Global Drugs for HIV Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Drugs for HIV Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Drugs for HIV Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Figure 6. Global Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Integrase Inhibitors
Figure 8. Global Integrase Inhibitors Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Combination HIV Medicines
Figure 10. Global Combination HIV Medicines Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Drugs for HIV Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Drugs for HIV Sales Market Share by Type in 2022 & 2034
Figure 15. North America Drugs for HIV Sales Market Share in Volume by Type in 2022
Figure 16. North America Drugs for HIV Sales Market Share in Value by Type in 2022
Figure 17. Europe Drugs for HIV Sales Market Share in Volume by Type in 2022
Figure 18. Europe Drugs for HIV Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Drugs for HIV Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Drugs for HIV Sales Market Share in Value by Type in 2022
Figure 21. Latin America Drugs for HIV Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Drugs for HIV Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Drugs for HIV Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Drugs for HIV Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Drugs for HIV Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Drugs for HIV Revenue in 2022
Figure 27. Drugs for HIV Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Hospital Pharmacies
Figure 29. Global Hospital Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Retail Pharmacies
Figure 31. Global Retail Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Online Pharmacies
Figure 33. Global Online Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Global Drugs for HIV Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Drugs for HIV Sales Market Share by Application in 2022 & 2034
Figure 38. North America Drugs for HIV Sales Market Share in Volume by Application in 2022
Figure 39. North America Drugs for HIV Sales Market Share in Value by Application in 2022
Figure 40. Europe Drugs for HIV Sales Market Share in Volume by Application in 2022
Figure 41. Europe Drugs for HIV Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Drugs for HIV Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Drugs for HIV Sales Market Share in Value by Application in 2022
Figure 44. Latin America Drugs for HIV Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Drugs for HIV Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Drugs for HIV Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Drugs for HIV Manufacturing Cost Structure
Figure 49. Drugs for HIV Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed